Get the Stockscreener App
5.54
4.14%
0.22
Prime Medicine Inc stock is traded at $5.54, with a volume of 3.23M.
It is up +4.14% in the last 24 hours and up +70.99% over the past month.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
See More
Previous Close:
$5.32
Open:
$5.33
24h Volume:
3.23M
Relative Volume:
0.77
Market Cap:
$745.54M
Revenue:
-
Net Income/Loss:
$-217.44M
P/E Ratio:
-2.553
EPS:
-2.17
Net Cash Flow:
$-205.20M
1W Performance:
+2.78%
1M Performance:
+70.99%
6M Performance:
+178.39%
1Y Performance:
+43.15%
1-Day Range:
$5.28
$5.63
1-Week Range:
$4.87
$5.63
52-Week Range:
$1.11
$5.63
Prime Medicine Inc Stock (PRME) Company Profile
Name
Prime Medicine Inc
Sector
Industry
Phone
617-465-0013
Address
60 FIRST ST., CAMBRIDGE
Compare PRME with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRME
Prime Medicine Inc
|
5.54 | 948.42M | 0 | -217.44M | -205.20M | -2.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Prime Medicine Inc Stock (PRME) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-27-25 | Downgrade | Citigroup | Buy → Neutral |
| May-20-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| May-20-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-10-24 | Initiated | JMP Securities | Mkt Outperform |
| May-20-24 | Initiated | H.C. Wainwright | Buy |
| May-16-24 | Upgrade | Citigroup | Neutral → Buy |
| Apr-22-24 | Initiated | Chardan Capital Markets | Buy |
| Apr-08-24 | Initiated | TD Cowen | Buy |
| Apr-03-24 | Initiated | Wedbush | Outperform |
| Jan-16-24 | Downgrade | Stifel | Buy → Hold |
| Dec-08-23 | Initiated | Citigroup | Neutral |
| Oct-09-23 | Initiated | BMO Capital Markets | Outperform |
| Jul-31-23 | Initiated | Guggenheim | Buy |
| Apr-18-23 | Initiated | Stifel | Buy |
| Nov-14-22 | Initiated | Goldman | Neutral |
| Nov-14-22 | Initiated | JP Morgan | Overweight |
| Nov-14-22 | Initiated | Jefferies | Buy |
| Nov-14-22 | Initiated | Morgan Stanley | Equal-Weight |
View All
Prime Medicine Inc Stock (PRME) Latest News
Prime Medicine (NASDAQ:PRME) Shares Up 3.9%Here's Why - MarketBeat
Septerna appoints Keith Gottesdiener to board of directors - Investing.com India
Former Prime Medicine CEO and 20+ Drug Approval Leader Keith Gottesdiener Joins Septerna's Board - Stock Titan
What earnings revisions data tells us about Prime Medicine Inc.July 2025 Momentum & Risk Adjusted Swing Trade Ideas - newser.com
Is Prime Medicine Inc. stock a buy on dips2025 Volatility Report & Real-Time Chart Pattern Alerts - newser.com
Is Prime Medicine Inc. stock entering bullish territoryTrade Volume Summary & High Win Rate Trade Alerts - newser.com
Using flow based indicators on Prime Medicine Inc.Quarterly Trade Review & Safe Capital Investment Plans - newser.com
Prime Medicine, Inc. Hits New 52-Week High of $5.20 - Markets Mojo
Prime Medicine (NASDAQ:PRME) Stock Price Down 5.6%What's Next? - MarketBeat
Prime Medicine (NYSE:PRME) Stock Price Down 5.1%What's Next? - MarketBeat
Goldman Sachs Group Inc. Lowers Stock Holdings in Prime Medicine, Inc. $PRME - MarketBeat
Prime Medicine Stock Soars 8.02%, Hits Intraday High of $5.43 - Markets Mojo
Prime Medicine, Inc. Hits New 52-Week High of $5.63 - Markets Mojo
Prime Medicine (NASDAQ:PRME) Shares Gap DownTime to Sell? - MarketBeat
Prime Medicine, Inc. $PRME Shares Purchased by Palumbo Wealth Management LLC - MarketBeat
Prime Medicine Unveils New Prime Editing Advancements - MSN
Prime Medicine, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Prime Medicine (NASDAQ:PRME) Hits New 12-Month HighWhat's Next? - MarketBeat
Prime Medicine Momentum Amid Pipeline Progress: Why I Choose To 'Hold' For Now (PRME) - Seeking Alpha
What machine learning models say about Prime Medicine Inc.2025 Major Catalysts & High Accuracy Trade Alerts - newser.com
Stock Traders Buy Large Volume of Call Options on Prime Medicine (NYSE:PRME) - MarketBeat
Prime Medicine (NASDAQ:PRME) Reaches New 52-Week HighHere's Why - MarketBeat
Prime Medicine (NYSE:PRME) Trading 5.4% HigherShould You Buy? - MarketBeat
Prime Medicine (NYSE:PRME) Shares Gap UpStill a Buy? - MarketBeat
Tech Rally: Should I trade or invest in Prime Medicine IncBond Market & Stepwise Swing Trade Plans - خودرو بانک
Prime Medicine (PRME): Evaluating Valuation After Recent LNP Innovations Spotlighted at Cell & Gene Therapy Conference - Yahoo Finance
Prime Medicine (NASDAQ:PRME) Trading 12.7% HigherShould You Buy? - MarketBeat
VIX Spike: Why is Prime Medicine Inc. stock going upWeekly Profit Summary & Community Trade Idea Sharing Platform - خودرو بانک
Meme Stocks: Is Prime Medicine Inc. backed by strong institutional buyingEarnings Summary Report & AI Enhanced Trading Signals - خودرو بانک
Panic Selling: Can Prime Medicine Inc. reach resistance levels soonPortfolio Gains Summary & High Accuracy Buy Signal Tips - خودرو بانک
Prime Medicine (NASDAQ:PRME) Shares Gap UpShould You Buy? - MarketBeat
S P Trends: Is Prime Medicine Inc. stock a smart retirement pick2025 Key Lessons & Real-Time Stock Price Movement Reports - khodrobank.com
Will Prime Medicine Inc stock hit new highs in YEARAnalyst Downgrade & Growth Oriented Trade Recommendations - khodrobank.com
Will Prime Medicine's (PRME) Innovation Messaging at CGTI Drive Lasting Competitive Advantage? - Yahoo Finance
Quarterly Earnings: What is Prime Medicine Inc.’s market position2025 Big Picture & High Accuracy Swing Entry Alerts - خودرو بانک
Prime Medicine, Inc. (NYSE:PRME) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Market Outlook: Is Prime Medicine Inc. forming higher highs and higher lowsQuarterly Growth Report & Breakout Confirmation Alerts - خودرو بانک
Fed Watch: What is the target price for Prime Medicine Inc stockTrade Exit Summary & Daily Price Action Insights - خودرو بانک
Why Cathie Wood is Loading Up on These 2 Growth Stocks (And Should You?) - yahoo.com
Merger Talk: What is Prime Medicine Inc.’s market position2025 Risk Factors & Verified Short-Term Plans - khodrobank.com
Stop Loss: Why is Prime Medicine Inc. stock going upWeekly Trade Report & Fast Gain Swing Trade Alerts - khodrobank.com
What is Prime Medicine Inc. s revenue forecastQuarterly Trade Summary & Expert Verified Movement Alerts - خودرو بانک
Head-To-Head Analysis: Prime Medicine (NYSE:PRME) and Big Cypress Acquisition (OTCMKTS:BCYP) - Defense World
What the charts say about Prime Medicine Inc. todayStock Surge & Low Drawdown Momentum Ideas - newser.com
Comparing Prime Medicine (NASDAQ:PRME) & Vor Biopharma (NASDAQ:VOR) - Defense World
Citi Downgrades Prime Medicine (PRME) to Neutral, Cuts PT to $1.50 Due to Market Uncertainty - MSN
Is Prime Medicine Inc. backed by strong institutional buyingStop Loss & Free High Accuracy Swing Entry Alerts - Lancaster City Council
Prime Medicine Inc. Breaks Losing Streak — Is the Trend ReversingJuly 2025 Institutional & Smart Allocation Stock Tips - beatles.ru
Prime Medicine (NASDAQ:PRME) Stock Price Down 3.7% After Analyst Downgrade - MarketBeat
What is Prime Medicine Inc.’s market position2025 Macro Impact & Advanced Swing Trade Entry Alerts - 뉴스영
Best data tools to analyze Prime Medicine Inc. stock2025 Bull vs Bear & Stock Portfolio Risk Control - Newser
Prime Medicine Inc Stock (PRME) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.36%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):